JP2024528489A - 相同修復欠損を分類するシステムおよび方法 - Google Patents

相同修復欠損を分類するシステムおよび方法 Download PDF

Info

Publication number
JP2024528489A
JP2024528489A JP2023579476A JP2023579476A JP2024528489A JP 2024528489 A JP2024528489 A JP 2024528489A JP 2023579476 A JP2023579476 A JP 2023579476A JP 2023579476 A JP2023579476 A JP 2023579476A JP 2024528489 A JP2024528489 A JP 2024528489A
Authority
JP
Japan
Prior art keywords
hrd
features
feature
tumor
genome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023579476A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024528489A5 (cg-RX-API-DMAC10.html
Inventor
イーサン ソコル，
ジェイ ムーア，
ジャスティン ニューバーグ，
デクスター ジン，
クイ－ティン チェン，
Original Assignee
ファウンデーション・メディシン・インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファウンデーション・メディシン・インコーポレイテッド filed Critical ファウンデーション・メディシン・インコーポレイテッド
Publication of JP2024528489A publication Critical patent/JP2024528489A/ja
Publication of JP2024528489A5 publication Critical patent/JP2024528489A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00—Machine learning
    • G06N20/20—Ensemble learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G06N3/09—Supervised learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N5/00—Computing arrangements using knowledge-based models
    • G06N5/01—Dynamic search techniques; Heuristics; Dynamic trees; Branch-and-bound
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Data Mining & Analysis (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Molecular Biology (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Artificial Intelligence (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Computing Systems (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Epidemiology (AREA)
  • Computational Linguistics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
JP2023579476A 2021-06-25 2022-06-24 相同修復欠損を分類するシステムおよび方法 Pending JP2024528489A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163215281P 2021-06-25 2021-06-25
US63/215,281 2021-06-25
PCT/US2022/073167 WO2022272310A1 (en) 2021-06-25 2022-06-24 System and method of classifying homologous repair deficiency

Publications (2)

Publication Number Publication Date
JP2024528489A true JP2024528489A (ja) 2024-07-30
JP2024528489A5 JP2024528489A5 (cg-RX-API-DMAC10.html) 2025-06-19

Family

ID=84545873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023579476A Pending JP2024528489A (ja) 2021-06-25 2022-06-24 相同修復欠損を分類するシステムおよび方法

Country Status (7)

Country Link
US (1) US20230140123A1 (cg-RX-API-DMAC10.html)
EP (1) EP4360094A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024528489A (cg-RX-API-DMAC10.html)
CN (1) CN117561572A (cg-RX-API-DMAC10.html)
AU (1) AU2022299105A1 (cg-RX-API-DMAC10.html)
TW (1) TW202317774A (cg-RX-API-DMAC10.html)
WO (1) WO2022272310A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260080973A1 (en) * 2022-08-30 2026-03-19 Foundation Medicine, Inc. Systems and methods for classifying and treating homologous repair deficiency cancers
US20260100247A1 (en) * 2022-09-30 2026-04-09 Foundation Medicine, Inc. Systems and methods for processing clinico-genomic data
WO2024077041A2 (en) * 2022-10-05 2024-04-11 Foundation Medicine, Inc. Methods and systems for identifying copy number signatures
CN116451070B (zh) * 2023-03-17 2025-12-19 南京康尼机电股份有限公司 基于多分辨率窗口的轨道车门系统异常判别方法及系统
EP4702163A1 (en) * 2023-04-28 2026-03-04 Institut Curie Methods for diagnosing a homologous recombination deficiency in human tumors
CN116312781B (zh) * 2023-05-17 2023-08-18 普瑞基准科技（北京）有限公司 一种基于机器学习的基因组不稳定性评估方法及系统
CN117011615B (zh) * 2023-09-15 2025-12-19 湖南自兴智慧医疗科技有限公司 基于生成式模型数据增广的微核血细胞识别系统
WO2025217185A1 (en) * 2024-04-09 2025-10-16 Foundation Medicine, Inc. Parp inhibitors for the treatment of advanced prostate cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200255909A1 (en) * 2019-02-12 2020-08-13 Tempus Integrated machine-learning framework to estimate homologous recombination deficiency
US20210172024A1 (en) * 2019-12-10 2021-06-10 Tempus Labs, Inc. Systems and methods for predicting homologous recombination deficiency status of a specimen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2981624T3 (da) * 2013-04-05 2020-03-02 Myriad Genetics Inc Fremgangsmåder til vurdering af homolog rekombinationsdeficiens og forudsigelse af respons på cancerbehandling
US11348661B2 (en) * 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200255909A1 (en) * 2019-02-12 2020-08-13 Tempus Integrated machine-learning framework to estimate homologous recombination deficiency
US20210172024A1 (en) * 2019-12-10 2021-06-10 Tempus Labs, Inc. Systems and methods for predicting homologous recombination deficiency status of a specimen

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDREAS GNIRKE ET AL.: "Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencin", NATURE BIOTECHNOLOGY [ONLINE], vol. 27, no. 2, JPN6026028774, February 2009 (2009-02-01), pages 182 - 189, ISSN: 0005903408 *
JILIANG TANG, SALEM ALELYANI, HUAN LIU: "Feature selection for classification: A review", DATA CLASSIFICATION: ALGORITHMS AND APPLICATIONS [ONLINE], JPN6026028775, 1 January 2014 (2014-01-01), pages 1 - 29, ISSN: 0005903409 *
TALIA GOLAN,ET AL.: "Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocar", GASTROENTEROLOGY [ONLINE], vol. 160, no. 6, JPN6026028776, May 2025 (2025-05-01), pages 2119 - 2132, ISSN: 0005903410 *

Also Published As

Publication number Publication date
US20230140123A1 (en) 2023-05-04
AU2022299105A1 (en) 2024-01-04
TW202317774A (zh) 2023-05-01
EP4360094A4 (en) 2025-04-23
EP4360094A1 (en) 2024-05-01
WO2022272310A1 (en) 2022-12-29
CN117561572A (zh) 2024-02-13

Similar Documents

Publication Publication Date Title
US12435375B2 (en) Methylation markers and targeted methylation probe panel
WO2022272310A1 (en) System and method of classifying homologous repair deficiency
EP3481966B1 (en) Methods for fragmentome profiling of cell-free nucleic acids
JP2024019413A (ja) ゲノムワイド統合による循環腫瘍ｄｎａの超音波感受性検出
US12590326B2 (en) Methods for fragmentome profiling of cell-free nucleic acids
CN113228190B (zh) 分类和/或鉴定癌症亚型的系统和方法
Juul et al. Non-coding cancer driver candidates identified with a sample-and position-specific model of the somatic mutation rate
CN108504555A (zh) 鉴别及评价肿瘤进展的装置和方法
US20230242992A1 (en) Methods of predicting cancer progression
US20260080973A1 (en) Systems and methods for classifying and treating homologous repair deficiency cancers
US20230253115A1 (en) Methods and systems for predicting in-vivo response to drug therapies
US20240360516A1 (en) Methods for the analysis of gene expression and uses thereof
JP2025521263A (ja) がん療法における相同組換え欠損を検出するための方法及びシステム
US20220301654A1 (en) Systems and methods for predicting and monitoring treatment response from cell-free nucleic acids
Guo et al. MyClone: rapid and precise reconstruction of clonal population structures for tumors
US20240175087A1 (en) Methods and systems for predicting cancer homologous recombination pathway deficiency, and determining treatment response
US20250342964A1 (en) Cancer Classification with Tissue of Origin Thresholding
Figueroa et al. Novel Hybrid Feature Selection Framework to Model Survival: A Pancreatic Cancer Perspective
Sharma et al. Computational Analysis of Expression and Interaction Data to Reveal Role of DNA Mismatch Repair in MSI, HNPCC and CRC
Lin et al. Combining mutation detection with fragmentomics features leads to improved tumor-informed ctDNA detection
WO2025248506A1 (en) Apparatus, method, and computer-readable storage medium for predicting patient response to parp inhibitor treatment
Lupat Automated Discovery of Interacting Genomic Events That Impact Cancer Survival by Using Data Mining and Machine Learning Techniques
HK40008790B (en) Methods for fragmentome profiling of cell-free nucleic acids
HK40008790A (en) Methods for fragmentome profiling of cell-free nucleic acids

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250611

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250611

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260707